SCNI

#5158
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5914 USD
-0.10%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
0.5901
0.5914
年范围
0.5500
1.0499
日变化
-0.10%
每月变动
-16.82%
6个月变化
-21.79%
年变化
-21.79%
前一天收盘价
0.5920
开盘价
0.5901
买价
卖价
最低价
0.5901
High
0.5914
交易量
2
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 2.0511 M
  • Employee 31
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
791.22
市销率
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

新闻